INTERVIEW: Roche's Dan Chen Talks Immuno-Oncology Combinations
The head of Roche/Genentech's immuno-oncology programs discussed the firm's combination strategy at the recent American Society of Clinical Oncology annual meeting in Chicago.
The head of Roche/Genentech's immuno-oncology programs discussed the firm's combination strategy at the recent American Society of Clinical Oncology annual meeting in Chicago.